colforsin has been researched along with alpha-aminopyridine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (34.62) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Blinks, JR; Endoh, M; Taira, N; Yanagisawa, T | 1 |
| Ahn, HS; Eardley, D; Prioli, N; Watkins, R | 1 |
| Simpson, LL | 1 |
| Alberts, P; Ogren, VR | 1 |
| Bowyer, JF; Weiner, N | 1 |
| Renit-Soria, J; Stinnakre, J; Van Renterghem, C | 1 |
| Bali, JP; Choquet, A; Galleyrand, JC; Magous, R | 1 |
| Cox, RT; Walker, RJ | 1 |
| Komajda, M | 1 |
| Clarke, W; Kung, HF; Kung, MP; Maayani, S; Zhuang, ZP | 1 |
| Bobirnac, I; Bruinvels, AT; Danzeisen, M; Gazi, L; Geisse, S; Hoyer, D; Schoeffter, P; Schüpbach, E; Sommer, B; Tricklebank, M | 1 |
| Assié, MB; Cosi, C; Koek, W | 1 |
| Assié, MB; Colpaert, FC; Cosi, C; Koek, W; Patoiseau, JF; Pauwels, PJ; Vacher, B | 1 |
| Cutz, E; Farragher, SM; Fu, XW; Pan, J; Wang, D; Wong, V | 1 |
| Chung, C; Dubé, D; Friesen, RW; Huang, Z; Kwok, E; Laliberté, F; Liu, S; Tota, MR; Veilleux, A; Young, A; Zhang, L | 1 |
| Beume, R; Hirrle, A; Marx, D; Tenor, H; Wohlsen, A | 1 |
| Basma, H; Fahrid, M; Gunji, Y; Holz, O; Kanaji, N; Liu, X; Magnussen, H; Michalski, J; Muller, KC; Nakanishi, M; Nelson, A; Nogel, S; Rabe, KF; Rennard, SI; Sato, T; Toews, ML; Wang, X | 1 |
| Bond, M; Cui, MZ; Duggirala, A; Hewer, RC; Hindmarch, CC; Kimura, TE; Newby, AC | 1 |
| Becq, F; Boinot, C; Ferru-Clément, R; Jollivet Souchet, M | 1 |
| Bond, M; Duggirala, A; Johnson, JL; Kimura, TE; Newby, AC; Sala-Newby, GB; Wu, YJ | 1 |
| Carrillo, JJ; Lin, HV; Wang, J | 1 |
| Aban, I; Boyles, SE; Chaudhry, IG; Chua, M; Gentzsch, M; Guimbellot, JS; Jaspers, I; Leach, JM; Quinney, NL | 1 |
| Boyles, SE; Cholon, DM; Gentzsch, M; Martino, MEB; Quinney, NL; Ribeiro, CMP | 1 |
| Bijvelds, MJC; Bose, SJ; Bot, AGM; Cai, Z; de Jonge, HR; Liu, J; Sheppard, DN; Wang, Y | 1 |
| Hanrahan, JW; Luo, Y; Thomas, DY; Turner, MJ | 1 |
| Beekman, JM; Graeber, SY; Hirtz, S; Kruisselbrink, E; Mall, MA; van der Ent, CK; van Mourik, P; Vonk, AM | 1 |
26 other study(ies) available for colforsin and alpha-aminopyridine
| Article | Year |
|---|---|
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Imidazoles; Male; Milrinone; Myocardial Contraction; Myocardium; Nifedipine; Nucleotides, Cyclic; Pyrazines; Pyridones; Quinolines; Time Factors | 1986 |
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Colforsin; Cyclic AMP; Enoximone; Guinea Pigs; Hydrolysis; Imidazoles; Isoenzymes; Milrinone; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridones | 1986 |
Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; Acetylcholine; Amifampridine; Aminopyridines; Ammonium Chloride; Animals; Botulinum Toxins; Calcium; Cholera Toxin; Colforsin; Female; Guanidine; Guanidines; In Vitro Techniques; Methylamines; Mice; Neuromuscular Junction; Neurotoxins; Tetanus Toxin; Theophylline | 1988 |
Interaction of forskolin with the effect of atropine on [3H]acetylcholine secretion in guinea-pig ileum myenteric plexus.
Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Aminopyridines; Animals; Atropine; Colforsin; Cyclic GMP; Drug Interactions; Guinea Pigs; Ileum; In Vitro Techniques; Myenteric Plexus; Neuromuscular Junction | 1988 |
K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Aminopyridines; Animals; Calcium; Colforsin; Dopamine; Ergolines; Ethylmaleimide; In Vitro Techniques; Pertussis Toxin; Potassium Channels; Quinpirole; Rats; Synaptosomes; Tetraethylammonium Compounds; Virulence Factors, Bordetella | 1989 |
beta-Adrenergic induced K+ current in Xenopus oocytes: role of cAMP, inhibition by muscarinic agents.
Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Adenosine; Aminobenzoates; Aminopyridines; Animals; Atropine; Calcimycin; Colforsin; Cyclic AMP; Diterpenes; Female; Isoproterenol; Oocytes; Phosphodiesterase Inhibitors; Potassium; Receptors, Adrenergic, beta; Tetraethylammonium Compounds; Xenopus laevis | 1985 |
[Is forskolin a stimulant of gastric secretion?].
Topics: Aminopyridines; Animals; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Gastric Acid; Gastrins; Histamine; Parietal Cells, Gastric; Rabbits; Rats | 1988 |
An analysis of the inhibitory responses of dopamine and octopamine on Helix central neurons.
Topics: 4-Aminopyridine; Adenylyl Cyclase Inhibitors; Aminopyridines; Animals; Bucladesine; Colforsin; Dopamine; Evoked Potentials; Helix, Snails; Imines; Membrane Potentials; Neuromuscular Depolarizing Agents; Neurons; Octopamine; Potassium Channels | 1988 |
[New cardiotonic agents].
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Colforsin; Deoxyepinephrine; Humans; Imidazoles; Levodopa; Milrinone; Practolol; Prenalterol; Propanolamines; Pyridones; Quinazolines; Xamoterol | 1985 |
A potential 5-HT1A receptor antagonist: p-MPPI.
Topics: Adenylyl Cyclases; Aminopyridines; Animals; Binding, Competitive; Colforsin; Guanosine Triphosphate; Hippocampus; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Ligands; Piperazines; Rats; Receptors, Serotonin; Serotonin Antagonists; Stimulation, Chemical | 1994 |
The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Topics: Aminopyridines; Antipsychotic Agents; Cell Line; Clozapine; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Humans; Kidney; Piperidines; Pyridines; Pyrroles; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone | 1998 |
Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Colforsin; GTP-Binding Protein alpha Subunits, Gi-Go; Guanylyl Imidodiphosphate; HeLa Cells; Hippocampus; Humans; In Vitro Techniques; Male; Membranes; Pertussis Toxin; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Virulence Factors, Bordetella | 1999 |
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Antidepressive Agents; Binding, Competitive; Buspirone; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); HeLa Cells; Humans; Male; Motor Activity; Piperazines; Piperidines; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2001 |
Neuroepithelial bodies in mammalian lung express functional serotonin type 3 receptor.
Topics: Aminopyridines; Animals; Calcium; Chemoreceptor Cells; Colforsin; Cricetinae; Dose-Response Relationship, Drug; Gene Expression; Humans; Immunohistochemistry; In Situ Hybridization; Indoles; Ion Channel Gating; Ketanserin; Lung; Mammals; Membrane Potentials; Mesocricetus; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Piperazines; Rabbits; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Respiratory Mucosa; RNA, Messenger; Serotonin; Serotonin Antagonists; Tropisetron | 2001 |
Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Aminopyridines; Benzamides; Biotransformation; Blotting, Western; Cell Line; Chlorides; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cystic Fibrosis Transmembrane Conductance Regulator; Enzyme Activation; Humans; Iodine Radioisotopes; Isoquinolines; Phosphodiesterase Inhibitors; Sulfonamides | 2005 |
Effect of cyclic AMP-elevating agents on airway ciliary beat frequency in central and lateral airways in rat precision-cut lung slices.
Topics: Aminopyridines; Animals; Benzamides; Colforsin; Cyclic AMP; Cyclopropanes; Dissection; Enzyme Inhibitors; Female; In Vitro Techniques; Lung; Mucociliary Clearance; Phosphodiesterase 4 Inhibitors; Prostaglandins; Rats; Rats, Wistar; Rolipram; Terbutaline; Time Factors | 2010 |
Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminopyridines; Benzamides; Cells, Cultured; Chemotaxis; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dinoprostone; Fibroblasts; Fibronectins; Gene Expression; Humans; Iloprost; Isoenzymes; Lung; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP2 Subtype; Rolipram; Second Messenger Systems | 2012 |
Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
Topics: Adenosine; Aminopyridines; Animals; Cell Proliferation; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Early Growth Response Protein 1; Epoprostenol; ets-Domain Protein Elk-1; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Human Umbilical Vein Endothelial Cells; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Specificity; Primary Cell Culture; Protein Binding; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Serum Response Factor; Signal Transduction | 2014 |
Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.
Topics: 1-Deoxynojirimycin; Aminopyridines; Benzamides; Benzodioxoles; Cell Survival; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; HeLa Cells; Humans; Thiazoles | 2014 |
cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.
Topics: Actin Cytoskeleton; Adenosine; Aminopyridines; Animals; Carotid Arteries; Cell Proliferation; Chemotaxis; Colforsin; Cyclic AMP; Cysteine-Rich Protein 61; Epoprostenol; Humans; Male; Mitogens; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Serum Response Factor; Trans-Activators; Transcription Factors; Transcription, Genetic | 2015 |
GPR142 Agonists Stimulate Glucose-Dependent Insulin Secretion via Gq-Dependent Signaling.
Topics: Aminopyridines; Animals; Colforsin; Cyclic AMP; Gene Expression Regulation; Glucose; HEK293 Cells; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Primary Cell Culture; Protein Subunits; Pyrazoles; Receptors, G-Protein-Coupled; Recombinant Proteins; Signal Transduction; Tryptophan | 2016 |
Nasospheroids permit measurements of CFTR-dependent fluid transport.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Biological Transport; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Mutation; Nasal Mucosa; Particle Size; Precision Medicine; Quinolones; Spheroids, Cellular | 2017 |
The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Bronchi; Cell Line; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Inflammation; Mutation; Quinolones; Respiratory System | 2018 |
Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.
Topics: Adenosine Triphosphate; Aminophenols; Aminopyridines; Animals; Base Sequence; Benzodioxoles; Chloride Channel Agonists; CHO Cells; Colforsin; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression; Genistein; Ion Transport; Mice; NIH 3T3 Cells; Patch-Clamp Techniques; Protein Stability; Quinolones; Sequence Deletion; Species Specificity; Temperature; Transgenes | 2019 |
The dual phosphodiesterase 3/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants.
Topics: Aminopyridines; Animals; Benzodioxoles; Bronchi; Cell Line; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Isoquinolines; Mutation; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Primary Cell Culture; Pyrimidinones; Rats; Rats, Inbred F344; Thyroid Epithelial Cells; Transgenes | 2020 |
Comparison of Organoid Swelling and
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Chlorides; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Edema; Female; Forced Expiratory Volume; Homozygote; Humans; In Vitro Techniques; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Organoids; Precision Medicine; Prospective Studies; Quinolones; Rectum; Sweat; Treatment Outcome; Vital Capacity; Young Adult | 2020 |